Transcriptional induction of cyclooxygenase-2 in osteoclast precursors is involved in RANKL-induced osteoclastogenesis

Song Yi Han, Na Kyung Lee, Kyung Hee Kim, In Whan Jang, Mijung Yim, Jae Hong Kim, Won Jae Lee, Soo Young Lee

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Regulation of osteoclast differentiation is key to understanding the pathogenesis and to developing treatments for bone diseases such as osteoporosis. To gain insight into the mechanism of the receptor activator of nuclear factor (NF)-κB ligand (RANKL)-specific induction of the osteoclast differentiation program, we took a suppression-subtractive hybridization screening approach to identify genes specifically induced via the RANKL-Rac1 signaling pathway. Among identified targets, we show that RANKL selectively induces cyclooxygenase (COX) 2 expression via Rac1 that results in turn in production of prostaglandin E2 (PGE2) in RAW 264.7 cells. By using transient transfection assays, we found that the -233/ -206 region of the COX-2 promoter gene was critical for RANKL-induced promoter activity. This RANKL-responsive region contained an NF-κB site that, when mutated, completely abolished the induction of NF-κB DMA-binding activity by RANKL. Blockade of COX-2 by celecoxib inhibits differentiation of bone marrow-derived monocyte/macrophage precursor cells (BMMs) into tartrate-resistant acid phosphatase-positive (TRAP+) osteoclastic cells. This inhibition can be rescued by the addition of exogenous PGE2, suggesting that COX-2-dependent PGE2 induction by RANKL in osteoclast precursors is required for osteoclast differentiation.

Original languageEnglish
Pages (from-to)1240-1245
Number of pages6
JournalBlood
Volume106
Issue number4
DOIs
Publication statusPublished - 2005 Aug 15

Fingerprint

Osteoclasts
Cyclooxygenase 2
Osteogenesis
Dinoprostone
Celecoxib
Bone
Monocyte-Macrophage Precursor Cells
Genes
Macrophages
Bone Diseases
Dynamic mechanical analysis
Cytoplasmic and Nuclear Receptors
Acid Phosphatase
Osteoporosis
Transfection
Assays
Screening
Ligands

ASJC Scopus subject areas

  • Hematology

Cite this

Transcriptional induction of cyclooxygenase-2 in osteoclast precursors is involved in RANKL-induced osteoclastogenesis. / Han, Song Yi; Lee, Na Kyung; Kim, Kyung Hee; Jang, In Whan; Yim, Mijung; Kim, Jae Hong; Lee, Won Jae; Lee, Soo Young.

In: Blood, Vol. 106, No. 4, 15.08.2005, p. 1240-1245.

Research output: Contribution to journalArticle

Han, Song Yi ; Lee, Na Kyung ; Kim, Kyung Hee ; Jang, In Whan ; Yim, Mijung ; Kim, Jae Hong ; Lee, Won Jae ; Lee, Soo Young. / Transcriptional induction of cyclooxygenase-2 in osteoclast precursors is involved in RANKL-induced osteoclastogenesis. In: Blood. 2005 ; Vol. 106, No. 4. pp. 1240-1245.
@article{ee0dbed56d304225824bac102c849150,
title = "Transcriptional induction of cyclooxygenase-2 in osteoclast precursors is involved in RANKL-induced osteoclastogenesis",
abstract = "Regulation of osteoclast differentiation is key to understanding the pathogenesis and to developing treatments for bone diseases such as osteoporosis. To gain insight into the mechanism of the receptor activator of nuclear factor (NF)-κB ligand (RANKL)-specific induction of the osteoclast differentiation program, we took a suppression-subtractive hybridization screening approach to identify genes specifically induced via the RANKL-Rac1 signaling pathway. Among identified targets, we show that RANKL selectively induces cyclooxygenase (COX) 2 expression via Rac1 that results in turn in production of prostaglandin E2 (PGE2) in RAW 264.7 cells. By using transient transfection assays, we found that the -233/ -206 region of the COX-2 promoter gene was critical for RANKL-induced promoter activity. This RANKL-responsive region contained an NF-κB site that, when mutated, completely abolished the induction of NF-κB DMA-binding activity by RANKL. Blockade of COX-2 by celecoxib inhibits differentiation of bone marrow-derived monocyte/macrophage precursor cells (BMMs) into tartrate-resistant acid phosphatase-positive (TRAP+) osteoclastic cells. This inhibition can be rescued by the addition of exogenous PGE2, suggesting that COX-2-dependent PGE2 induction by RANKL in osteoclast precursors is required for osteoclast differentiation.",
author = "Han, {Song Yi} and Lee, {Na Kyung} and Kim, {Kyung Hee} and Jang, {In Whan} and Mijung Yim and Kim, {Jae Hong} and Lee, {Won Jae} and Lee, {Soo Young}",
year = "2005",
month = "8",
day = "15",
doi = "10.1182/blood-2004-12-4975",
language = "English",
volume = "106",
pages = "1240--1245",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "4",

}

TY - JOUR

T1 - Transcriptional induction of cyclooxygenase-2 in osteoclast precursors is involved in RANKL-induced osteoclastogenesis

AU - Han, Song Yi

AU - Lee, Na Kyung

AU - Kim, Kyung Hee

AU - Jang, In Whan

AU - Yim, Mijung

AU - Kim, Jae Hong

AU - Lee, Won Jae

AU - Lee, Soo Young

PY - 2005/8/15

Y1 - 2005/8/15

N2 - Regulation of osteoclast differentiation is key to understanding the pathogenesis and to developing treatments for bone diseases such as osteoporosis. To gain insight into the mechanism of the receptor activator of nuclear factor (NF)-κB ligand (RANKL)-specific induction of the osteoclast differentiation program, we took a suppression-subtractive hybridization screening approach to identify genes specifically induced via the RANKL-Rac1 signaling pathway. Among identified targets, we show that RANKL selectively induces cyclooxygenase (COX) 2 expression via Rac1 that results in turn in production of prostaglandin E2 (PGE2) in RAW 264.7 cells. By using transient transfection assays, we found that the -233/ -206 region of the COX-2 promoter gene was critical for RANKL-induced promoter activity. This RANKL-responsive region contained an NF-κB site that, when mutated, completely abolished the induction of NF-κB DMA-binding activity by RANKL. Blockade of COX-2 by celecoxib inhibits differentiation of bone marrow-derived monocyte/macrophage precursor cells (BMMs) into tartrate-resistant acid phosphatase-positive (TRAP+) osteoclastic cells. This inhibition can be rescued by the addition of exogenous PGE2, suggesting that COX-2-dependent PGE2 induction by RANKL in osteoclast precursors is required for osteoclast differentiation.

AB - Regulation of osteoclast differentiation is key to understanding the pathogenesis and to developing treatments for bone diseases such as osteoporosis. To gain insight into the mechanism of the receptor activator of nuclear factor (NF)-κB ligand (RANKL)-specific induction of the osteoclast differentiation program, we took a suppression-subtractive hybridization screening approach to identify genes specifically induced via the RANKL-Rac1 signaling pathway. Among identified targets, we show that RANKL selectively induces cyclooxygenase (COX) 2 expression via Rac1 that results in turn in production of prostaglandin E2 (PGE2) in RAW 264.7 cells. By using transient transfection assays, we found that the -233/ -206 region of the COX-2 promoter gene was critical for RANKL-induced promoter activity. This RANKL-responsive region contained an NF-κB site that, when mutated, completely abolished the induction of NF-κB DMA-binding activity by RANKL. Blockade of COX-2 by celecoxib inhibits differentiation of bone marrow-derived monocyte/macrophage precursor cells (BMMs) into tartrate-resistant acid phosphatase-positive (TRAP+) osteoclastic cells. This inhibition can be rescued by the addition of exogenous PGE2, suggesting that COX-2-dependent PGE2 induction by RANKL in osteoclast precursors is required for osteoclast differentiation.

UR - http://www.scopus.com/inward/record.url?scp=23744503049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23744503049&partnerID=8YFLogxK

U2 - 10.1182/blood-2004-12-4975

DO - 10.1182/blood-2004-12-4975

M3 - Article

C2 - 15860667

AN - SCOPUS:23744503049

VL - 106

SP - 1240

EP - 1245

JO - Blood

JF - Blood

SN - 0006-4971

IS - 4

ER -